These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11890884)

  • 1. Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy.
    Rubin MR; Silverberg SJ
    Curr Rheumatol Rep; 2002 Apr; 4(2):179-85. PubMed ID: 11890884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked direct suppression of primary hyperparathyroidism with osteitis fibrosa cystica by intravenous administration of 1,25-dihydroxycholecalciferol.
    Patron P; Gardin JP; Borensztein P; Prigent A; Paillard M
    Miner Electrolyte Metab; 1989; 15(6):321-5. PubMed ID: 2615719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteitis fibrosa cystica-a forgotten radiological feature of primary hyperparathyroidism.
    Misiorowski W; Czajka-Oraniec I; Kochman M; Zgliczyński W; Bilezikian JP
    Endocrine; 2017 Nov; 58(2):380-385. PubMed ID: 28900835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone disease in primary hyperparathyroidism.
    Parisien M; Silverberg SJ; Shane E; Dempster DW; Bilezikian JP
    Endocrinol Metab Clin North Am; 1990 Mar; 19(1):19-34. PubMed ID: 2192867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium pyrophosphate crystal deposition disease and hyperparathyroidism: a controlled, prospective study.
    Rynes RI; Merzig EG
    J Rheumatol; 1978; 5(4):460-8. PubMed ID: 216803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
    Brossard JH; Garon J; Lepage R; Gascon-Barré M; D'Amour P
    Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musculoskeletal manifestations of primary hyperparathyroidism.
    Pappu R; Jabbour SA; Reginato AM; Reginato AJ
    Clin Rheumatol; 2016 Dec; 35(12):3081-3087. PubMed ID: 27815654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis.
    Parfitt AM
    Metabolism; 1976 Oct; 25(10):1157-88. PubMed ID: 787723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum parathyroid hormone levels in patients with calcium pyrophosphate crystal deposition disease (chondrocalcinosis, pseudogout).
    Phelps P; Hawker CD
    Arthritis Rheum; 1973; 16(5):590-6. PubMed ID: 4742841
    [No Abstract]   [Full Text] [Related]  

  • 10. [Parathyroid dysfunction and rheumatic manifestations].
    Frey DP
    Z Rheumatol; 2011 Nov; 70(9):740-4, 746. PubMed ID: 21989974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum vitamin d status and clinical manifestations of primary hyperparathyroidism.
    Bandeira F; Caldas G; Freese E; Griz L; Faria M; Bandeira C
    Endocr Pract; 2002; 8(4):266-70. PubMed ID: 12173912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary hyperparathyroidism viewed as a bihormonal disease process.
    Broadus AE
    Miner Electrolyte Metab; 1982; 8(3-4):199-214. PubMed ID: 6300631
    [No Abstract]   [Full Text] [Related]  

  • 14. A rare case describing catastrophic destruction of the whole skeleton caused by severe hyperparathyroidism.
    Akkas BE; Demirel BB; Unlu EN; Ucmak G
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26491001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of chondrocalcinosis in patients with primary hyperparathyroidism in Japan.
    Yashiro T; Okamoto T; Tanaka R; Ito K; Hara H; Yamashita T; Kanaji Y; Kodama T; Ito Y; Obara T
    Endocrinol Jpn; 1991 Oct; 38(5):457-64. PubMed ID: 1843264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperparathyroidism with osteitis fibrosa cystica in the maxilla.
    Shanmugham MS; Alhady SF
    J Laryngol Otol; 1984 Apr; 98(4):417-20. PubMed ID: 6715975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery pattern of patients with osteitis fibrosa cystica in primary hyperparathyroidism after successful parathyroidectomy.
    Agarwal G; Mishra SK; Kar DK; Singh AK; Arya V; Gupta SK; Mithal A
    Surgery; 2002 Dec; 132(6):1075-83; discussion 1083-5. PubMed ID: 12490858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parathyroid hormone in osteoporosis].
    Cormier C
    Presse Med; 2006 Mar; 35(3 Pt 2):495-501. PubMed ID: 16550149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D status in primary hyperparathyroidism in India.
    Harinarayan CV; Gupta N; Kochupillai N
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):351-8. PubMed ID: 7586606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudogout as a clue and complication in primary hyperparathyroidism.
    Geelhoed GW; Kelly TR
    Surgery; 1989 Dec; 106(6):1036-41, discussion 1041-2. PubMed ID: 2588110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.